Catalent Spray Drying Technology: From Development to Manufacturing
Summary: Poorly soluble compounds continue to make up a large share of the pharmaceutical development pipeline. Spray drying has been proven for particle size engineering and known to improve the bioavailability of poorly soluble compounds. Catalent offers end-to-end spray drying solutions from early-phase development through to clinical supply, and scale-up to commercial finished dose forms.